多功能天然聚合物纳米颗粒作为抗纤维化基因载体治疗慢性肾脏病
该研究将表达BMP7或HGF/NK1的质粒DNA封装于透明质酸包覆的壳聚糖纳米颗粒,经静脉尾注射至单侧输尿管梗阻CKD小鼠模型,约40%-45%的基因在肾脏被摄取,纳米颗粒减轻纤维化并改善肾功能;BMP7逆转纤维化进展并促进肾小管再生,HGF/NK1通过消除胶原纤维沉积阻止CKD进展。
要点
- 透明质酸包覆壳聚糖纳米颗粒可安全递送BMP7或HGF/NK1质粒至肾脏。
- 静脉尾注射后约40%-45%的基因在肾脏被摄取。
- BMP7逆转纤维化并再生肾小管,HGF/NK1消除胶原沉积阻止CKD进展。
核心结论
- 纳米颗粒递送HGF/NK1具有强效抗纤维化和促再生作用,为CKD治疗提供概念验证。
研究设计与样本
- 研究聚焦于将表达BMP7或HGF/NK1的质粒DNA封装于透明质酸包覆的壳聚糖纳米颗粒,并在单侧输尿管梗阻CKD小鼠模型中进行非侵入性递送评估。
主要发现
- 合成含BMP7或HGF/NK1质粒DNA的透明质酸包覆壳聚糖纳米颗粒尺寸均一,经CD44+细胞内吞后促进细胞生长并抑制体外纤维化基因表达。
- 静脉尾注射后约40%-45%的基因在肾脏被摄取,纳米颗粒减轻单侧输尿管梗阻小鼠模型的纤维化并改善肾功能。
- BMP7基因递送逆转纤维化进展并再生肾小管,而HGF/NK1递送通过消除胶原纤维沉积阻止CKD进展。
临床怎么用
- 该纳米颗粒递送系统尚处于临床前概念验证阶段,暂未提供临床用药推荐。
局限性
- 研究仅基于单侧输尿管梗阻小鼠模型,尚未在人体或其它CKD模型中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Progressive fibrosis is the underlying pathophysiological process of CKD, and targeted prevention or reversal of the profibrotic cell phenotype is an important goal in developing therapeutics for CKD. Nanoparticles offer new ways to deliver antifibrotic therapies to damaged tissues and resident cells to limit manifestation of the profibrotic phenotype. METHODS: We focused on delivering plasmid DNA expressing bone morphogenetic protein 7 (BMP7) or hepatocyte growth factor (HGF)-NK1 (HGF/NK1) by encapsulation within chitosan nanoparticles coated with hyaluronan, to safely administer multifunctional nanoparticles containing the plasmid DNA to the kidneys for localized and sustained expression of antifibrotic factors. We characterized and evaluated nanoparticles in vitro for biocompatibility and antifibrotic function. To assess antifibrotic activity in vivo, we used noninvasive delivery to unilateral ureteral obstruction mouse models of CKD. RESULTS: Synthesis of hyaluronan-coated chitosan nanoparticles containing plasmid DNA expressing either BMP7 or NGF/NKI resulted in consistently sized nanoparticles, which-following endocytosis driven by CD44+ cells-promoted cellular growth and inhibited fibrotic gene expression in vitro. Intravenous tail injection of these nanoparticles resulted in approximately 40%-45% of gene uptake in kidneys in vivo. The nanoparticles attenuated the development of fibrosis and rescued renal function in unilateral ureteral obstruction mouse models of CKD. Gene delivery of BMP7 reversed the progression of fibrosis and regenerated tubules, whereas delivery of HGF/NK1 halted CKD progression by eliminating collagen fiber deposition. CONCLUSIONS: Nanoparticle delivery of HGF/NK1 conveyed potent antifibrotic and proregenerative effects. Overall, this research provided the proof of concept on which to base future investigations for enhanced targeting and transfection of therapeutic genes to kidney tissues, and an avenue toward treatment of CKD.
引用
- Midgley AC, Wei Y, Zhu D, et al. Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy. J Am Soc Nephrol. 2020. PMID: 32769144. doi:10.1681/ASN.2019111160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。